ArticleScience translational medicine2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.
Scott G Hansen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this papertrialcites it